Bridgewater Associates’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $20.3M | Buy |
|
|||||
|
2025
Q2 | $12.5M | Buy |
|
|||||
|
2025
Q1 | $8.74M | Sell |
|
|||||
|
2024
Q4 | $19.9M | Buy |
|
|||||
|
2024
Q3 | $10M | Buy |
|
|||||
|
2024
Q2 | $2.88M | Buy |
|
|||||
|
2024
Q1 | $294K | Sell |
|
|||||
|
2023
Q4 | $18.4M | Buy |
|
|||||
|
2023
Q3 | $14.3M | Buy |
|
|||||
|
2023
Q2 | $13M | Buy |
|
|||||
|
2023
Q1 | $12.1M | Buy |
|
|||||
|
2022
Q4 | $11M | Sell |
|
|||||
|
2022
Q3 | $9.12M | Buy |
|
|||||
|
2022
Q2 | $3.29M | Buy |
|
|||||
|
2022
Q1 | $1.51M | Buy |
|
|||||
|
2021
Q4 | $1.24M | Sell |
|
|||||
|
2021
Q3 | $1.08M | Sell |
|
|||||
|
2021
Q2 | $1.93M | Buy |
|
|||||
|
2021
Q1 | $1.01M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $826K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $3.3M | Buy |
|